Literature DB >> 1362219

Receptor-mediated methylprednisolone pharmacodynamics in rats: steroid-induced receptor down-regulation.

D B Haughey1, W J Jusko.   

Abstract

Several approaches to receptor down-regulation were examined to extend previous receptor/gene-mediated pharmacokinetic/dynamic models of corticosteroids. Down-regulation of the glucocorticoid receptor was considered as an instantaneous event or as a gradual steroid-receptor-mediated process. Concentrations of plasma methylprednisolone, free hepatic cytosolic receptors, and the activity of hepatic tyrosine aminotransferase (TAT) enzyme were measured for 16 hr following administration of 0, 10, and 50 mg/kg methylprednisolone sodium succinate to 93 adrenalectomized rats. Receptor down-regulation was best described by a fractional decrement in the rate of return of free cytosolic glucocorticoid receptor. Predicted values for free receptor, bound receptor, nuclear bound receptor, and transfer compartments were in accord with the expected rank order values based on the high and low steroid doses. Model parameter estimates were independent of dose and described the rapid depletion of free cytosolic receptor, late-phase return of cytosolic receptor to a new baseline level that was 20-40% lower than control, and the TAT induction/dissipation pattern following steroid dosing. The microscopic association and dissociation constants describing the steroid-receptor interaction were 0.23 L/nmole per hr (k(on)) and 4.74 hr-1 (k(off)) for methylprednisolone compared to previously obtained values of 0.20 L/nmole per hr and 15.7 hr-1 for the related steroid prednisolone. The time course of TAT induction was similar to that observed previously for prednisolone. Efficiency of TAT induction was more closely related to steroid receptor occupancy than plasma methylprednisolone concentrations due to receptor saturability and receptor recycling.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362219     DOI: 10.1007/bf01062462

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  29 in total

Review 1.  Glucocorticoid receptors and actions.

Authors:  A Munck; D B Mendel; L I Smith; E Orti
Journal:  Am Rev Respir Dis       Date:  1990-02

2.  Second generation model for prednisolone pharmacodynamics in the rat.

Authors:  A I Nichols; F D Boudinot; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

3.  Tissue-specific regulation of glucocorticoid receptor mRNA by dexamethasone.

Authors:  J E Kalinyak; R I Dorin; A R Hoffman; A J Perlman
Journal:  J Biol Chem       Date:  1987-08-05       Impact factor: 5.157

4.  Cyclic, nonequilibrium models of glucocorticoid antagonism: role of activation, nuclear binding and receptor recycling.

Authors:  A Munck; N J Holbrook
Journal:  J Steroid Biochem       Date:  1988-10       Impact factor: 4.292

5.  LAGRAN program for area and moments in pharmacokinetic analysis.

Authors:  M L Rocci; W J Jusko
Journal:  Comput Programs Biomed       Date:  1983-06

6.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

7.  Glucocorticoids regulate the glucocorticoid receptor in the AtT-20 cell.

Authors:  F Svec; M Rudis
Journal:  J Biol Chem       Date:  1981-06-25       Impact factor: 5.157

8.  Methylprednisolone disposition in rabbits. Analysis, prodrug conversion, reversible metabolism, and comparison with man.

Authors:  W F Ebling; S J Szefler; W J Jusko
Journal:  Drug Metab Dispos       Date:  1985 May-Jun       Impact factor: 3.922

9.  Dynamics of glucocorticoid receptor and induction of tyrosine aminotransferase in rat liver.

Authors:  M Izawa; A Yoshida; S Ichii
Journal:  Endocrinol Jpn       Date:  1982-04

10.  Receptor-mediated prednisolone pharmacodynamics in rats: model verification using a dose-sparing regimen.

Authors:  A I Nichols; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1990-06
View more
  9 in total

1.  Utility of cleavable isotope-coded affinity-tagged reagents for quantification of low-copy proteins induced by methylprednisolone using liquid chromatography/tandem mass spectrometry.

Authors:  Jun Qu; William J Jusko; Robert M Straubinger
Journal:  Anal Chem       Date:  2006-07-01       Impact factor: 6.986

2.  Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.

Authors:  Y N Sun; D C DuBois; R R Almon; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1998-06

3.  Third-generation model for corticosteroid pharmacodynamics: roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver.

Authors:  Z X Xu; Y N Sun; D C DuBois; R R Almon; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

4.  Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.

Authors:  Y N Sun; D C DuBois; R R Almon; N A Pyszczynski; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1998-12

5.  Enhancement of tissue delivery and receptor occupancy of methylprednisolone in rats by a liposomal formulation.

Authors:  E V Mishina; R M Straubinger; N A Pyszczynski; W J Jusko
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

6.  Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids.

Authors:  Anasuya Hazra; Nancy Pyszczynski; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-06-26       Impact factor: 2.745

7.  Pharmacokinetics of methylprednisolone after intravenous and intramuscular administration in rats.

Authors:  Anasuya Hazra; Nancy Pyszczynski; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2007-09       Impact factor: 1.627

8.  Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.

Authors:  Rohini Ramakrishnan; Debra C DuBois; Richard R Almon; Nancy A Pyszczynski; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-02       Impact factor: 2.745

9.  Assessing the dynamics of nuclear glucocorticoid-receptor complex: adding flexibility to gene expression modeling.

Authors:  Anasuya Hazra; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-02-07       Impact factor: 2.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.